Terms: = Lung cancer AND H3F3A, P84243, H3_3B, MGC87783, MGC87782, H3F3, H3_3A, ENSG00000163041, 3020
32 results:
1. Cycle-generative adversarial network-based bone suppression imaging for highly accurate markerless motion tracking of lung tumors for cyberknife irradiation therapy.
Mochizuki Z; Saito M; Suzuki T; Mochizuki K; Hasegawa J; Nemoto H; Satani K; Takahashi H; Onishi H
J Appl Clin Med Phys; 2024 Jan; 25(1):e14212. PubMed ID: 37985163
[TBL] [Abstract] [Full Text] [Related]
2. Knockout tales: the versatile roles of histone H3.3 in development and disease.
Klein RH; Knoepfler PS
Epigenetics Chromatin; 2023 Oct; 16(1):38. PubMed ID: 37814296
[TBL] [Abstract] [Full Text] [Related]
3. [
Peng L; Liao Y; Zhou R; Zhong Y; Jiang H; Wang J; Fu Y; Xue L; Zhang X; Sun M; Feng G; Meng Z; Peng S; He X; Teng G; Gao X; Zhang H; Tian M
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3723-3734. PubMed ID: 37401938
[TBL] [Abstract] [Full Text] [Related]
4. Multicentric Giant Cell Tumor of Bone.
Errani C; Tsukamoto S; Angulo Alvarado R; Righi A; Nitta Y; Donati DM; Mavrogenis AF
Orthopedics; 2023; 46(6):e376-e380. PubMed ID: 37126833
[TBL] [Abstract] [Full Text] [Related]
5. Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors.
Cao GZ; Ma LY; Zhang ZH; Wang XL; Hua JH; Zhang JH; Lv Y; Zhang SB; Ou J; Lin WC
Acta Pharmacol Sin; 2023 Apr; 44(4):841-852. PubMed ID: 36253561
[TBL] [Abstract] [Full Text] [Related]
6. Malignant Transformation of Giant Cell Tumour of Bone: A Review of Literature and the Experience of a Referral Centre.
Vari S; Riva F; Onesti CE; Cosimati A; Renna D; Biagini R; Baldi J; Zoccali C; Anelli V; Annovazzi A; Covello R; Ascione A; Casini B; Ferraresi V
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142631
[TBL] [Abstract] [Full Text] [Related]
7. Chondroblastoma-like osteosarcoma: a clinicopathological and molecular study of a rare osteosarcoma variant.
Gaeta R; Righi A; Gambarotti M; Aretini P; Lessi F; Mazzanti CM; Mancini I; Pinzani P; Belgio B; Sbaraglia M; Tos APD; Franchi A
Histopathology; 2022 Sep; 81(3):389-401. PubMed ID: 35791778
[TBL] [Abstract] [Full Text] [Related]
8. Differential proteome and functional analysis of NSCLC cell lines in response to Tualang honey treatment.
Amran N; Abdul-Rahman PS
J Ethnopharmacol; 2022 Jul; 293():115264. PubMed ID: 35398242
[TBL] [Abstract] [Full Text] [Related]
9. Corticosteroid administration for cancer-related indications is an unfavorable prognostic factor in solid cancer patients receiving immune checkpoint inhibitor treatment.
Wang Y; Yang M; Tao M; Liu P; Kong C; Li H; Chen Y; Yin X; Yan X
Int Immunopharmacol; 2021 Oct; 99():108031. PubMed ID: 34358857
[TBL] [Abstract] [Full Text] [Related]
10. [Prognostic factor analysis of patients with unresectablelung squamous cell carcinoma].
Gao X; Li Z; Shao XY; Liu XM; Liu C; Liu YP; Qu XJ; Zhang LY
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):569-573. PubMed ID: 34034477
[No Abstract] [Full Text] [Related]
11. Malignant Transformation of Giant Cell Tumor of Bone 7 years After Initial Surgery: A Case Report and Literature Review.
Matsunobu T; Maekawa A; Jotatsu M; Makihara K; Hisaoka M; Iwamoto Y
JBJS Case Connect; 2021 Apr; 11(2):. PubMed ID: 33878040
[TBL] [Abstract] [Full Text] [Related]
12. Mutation profile of non-small cell lung cancer revealed by next generation sequencing.
Chang YS; Tu SJ; Chen YC; Liu TY; Lee YT; Yen JC; Fang HY; Chang JG
Respir Res; 2021 Jan; 22(1):3. PubMed ID: 33407425
[TBL] [Abstract] [Full Text] [Related]
13. Patient Preferences For Specialty Pharmacy Services: A Stated Preference Discrete-Choice Experiment in China.
Hu Q; Hu H; Hu M; Yang Y; Wu Z; Zhou N
Front Public Health; 2020; 8():597389. PubMed ID: 33363089
[No Abstract] [Full Text] [Related]
14. Bilateral lung Metastases From a Phalangeal Giant Cell Tumor of Bone.
Orr A; Liu H; Mariani R; Aldrink JH; Setty BA; Koo S
Pediatr Dev Pathol; 2021; 24(1):51-55. PubMed ID: 33023391
[TBL] [Abstract] [Full Text] [Related]
15. h3f3a G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.
Gong L; Bui MM; Zhang W; Sun X; Zhang M; Yi D
Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329
[TBL] [Abstract] [Full Text] [Related]
16. Drivers underpinning the malignant transformation of giant cell tumour of bone.
Fittall MW; Lyskjaer I; Ellery P; Lombard P; Ijaz J; Strobl AC; Oukrif D; Tarabichi M; Sill M; Koelsche C; Mechtersheimer G; Demeulemeester J; Tirabosco R; Amary F; Campbell PJ; Pfister SM; Jones DT; Pillay N; Van Loo P; Behjati S; Flanagan AM
J Pathol; 2020 Dec; 252(4):433-440. PubMed ID: 32866294
[TBL] [Abstract] [Full Text] [Related]
17. The two faces of giant cell tumor of bone.
Scotto di Carlo F; Whyte MP; Gianfrancesco F
Cancer Lett; 2020 Oct; 489():1-8. PubMed ID: 32502498
[TBL] [Abstract] [Full Text] [Related]
18. Locally Aggressive Giant Cell Tumor of Bone With Pulmonary Distant Metastasis and Extrapulmonary Seeding in Pregnancy.
Murshed KA; Elsayed AM; Szabados L; Rashid S; Ammar A
J Am Acad Orthop Surg Glob Res Rev; 2020 Jan; 4(1):. PubMed ID: 32159067
[TBL] [Abstract] [Full Text] [Related]
19. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
20. Laparoscopic-assisted colorectal surgery benefits visceral obesity patients: a propensity-matched analysis.
Ye XZ; Chen XY; Ruan XJ; Chen WZ; Ma LL; Dong QT; Cai HY; Yu Z; Chen XL
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):786-791. PubMed ID: 31150364
[TBL] [Abstract] [Full Text] [Related]
[Next]
